Healthcare & Life Sciences

NeUmiRNa Therapeutics

NeUmiRNa Therapeutics is a Healthcare & Life Sciences startup based in All, most recent round Series B, 2 tracked investors.

stubseries-b
series-b
Stage
2021
Founded
2
Investors

About NeUmiRNa Therapeutics

NeUmiRNa Therapeutics is a startup founded in 2021 based in All. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Neumirna Therapeutics develops microRNA (miRNA)-based therapies that target root causes of neurological diseases to restore healthy neural network function, with programs focused on conditions such as epilepsy and Parkinson’s disease.

Explore NeUmiRNa Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in All